Utah Medical Products, Inc.
General ticker "UTMD" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $197.2M (TTM average)
Utah Medical Products, Inc. follows the US Stock Market performance with the rate: 43.8%.
Estimated limits based on current volatility of 1.9%: low 66.71$, high 69.24$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-03-17, amount 0.31$ (Y1.89%)
- Total employees count: 169 (-9.1%) as of 2023
- Top business risk factors: Government healthcare policies, Regulatory and compliance, GPO influence and costs, Product liability, Trade tariffs
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [50.54$, 69.07$]
- 2026-12-31 to 2027-12-31 estimated range: [54.94$, 73.93$]
Financial Metrics affecting the UTMD estimates:
- Negative: with PPE of 16.3 at the end of fiscal year the price was very high
- Positive: 6.59 < Operating cash flow per share per price, % of 7.82
- Positive: Operating profit margin, % of 29.60 > 18.39
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.43 > 6.06
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.20 > -0.60
- Positive: Inventory ratio change, % of -0.64 <= 0
- Positive: Shareholder equity ratio, % of 97.33 > 64.29
Short-term UTMD quotes
Long-term UTMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $50.22MM | $40.90MM | $38.52MM |
| Operating Expenses | $33.45MM | $27.31MM | $27.12MM |
| Operating Income | $16.78MM | $13.59MM | $11.40MM |
| Non-Operating Income | $3.31MM | $3.21MM | $2.71MM |
| R&D Expense | $0.56MM | $0.81MM | $0.67MM |
| Income(Loss) | $20.09MM | $16.80MM | $14.11MM |
| Taxes | $3.45MM | $2.93MM | $2.82MM |
| Net Income(Loss)* | $16.64MM | $13.87MM | $11.29MM |
| Stockholders Equity | $128.31MM | $117.43MM | $119.27MM |
| Inventory | $9.58MM | $8.81MM | $7.93MM |
| Assets | $135.46MM | $122.54MM | $122.54MM |
| Operating Cash Flow | $22.28MM | $14.83MM | $14.69MM |
| Capital expenditure | $0.64MM | $0.23MM | $0.37MM |
| Investing Cash Flow | $-0.64MM | $-0.21MM | $-0.37MM |
| Financing Cash Flow | $-4.17MM | $-23.84MM | $-12.34MM |
| Earnings Per Share** | $4.57 | $3.96 | $3.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.